Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 3, 2013
Comparison of response evaluation in patients with gastroenteropancreatic and thoracic neuroendocrine tumors after treatment with [177Lu-DOTA0,Tyr3]octreotateEsther I van Vliet, Eric P Krenning, Jaap J Teunissen, et al.Neuroendocrinology|January 13, 2012
Treatment of gastroenteropancreatic neuroendocrine tumors with peptide receptor radionuclide therapyEsther I van Vliet, Jaap J M Teunissen, Boen L R Kam, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 12, 2012
Tumor response assessment to treatment with [177Lu-DOTA0,Tyr3]octreotate in patients with gastroenteropancreatic and bronchial neuroendocrine tumors: differential response of bone versus soft-tissue lesionsEsther I van Vliet, John J Hermans, Maria A de Ridder, et al.Best Practice & Research. Clinical Gastroenterology|April 16, 2013
Peptide receptor radionuclide therapy (PRRT) for GEP-NETsHendrik Bergsma, Esther I van Vliet, Jaap J M Teunissen, et al.European Journal of Nuclear Medicine and Molecular Imaging|July 24, 2013
Hypocalcaemia after treatment with [177Lu-DOTA 0,Tyr3]octreotateEsther I van Vliet, Wouter W de Herder, Yolanda B de Rijke, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 15, 2015
Neoadjuvant Treatment of Nonfunctioning Pancreatic Neuroendocrine Tumors with [177Lu-DOTA0,Tyr3]OctreotateEsther I van Vliet, Casper H van Eijck, Ronald R de Krijger, et al.Pageof 1